Results 281 to 290 of about 870,585 (309)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Author Correction: Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine. [PDF]

open access: yesNPJ Vaccines
Bhattacharya A   +13 more
europepmc   +1 more source

Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate. [PDF]

open access: yesBiomedicines
Bazylewicz M   +10 more
europepmc   +1 more source

Kidney Transplantation and Cellular Immunity Dynamics: Immune Cell Alterations and Association with Clinical and Laboratory Parameters. [PDF]

open access: yesJ Clin Med
Vagiotas L   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Metabolomics in cancer research and emerging applications in clinical oncology

Ca-A Cancer Journal for Clinicians, 2021
Daniel R Schmidt   +2 more
exaly  

Home - About - Disclaimer - Privacy